Evidence map›Paper›PMID 32949098›Full record

ArticlePediatric transplantation2021

The pediatric solid organ transplant experience with COVID-19: An initial multi-center, multi-organ case series.

Matthew B Goss, N Thao N Galván, Wenly Ruan, Flor M Munoz, Eileen D Brewer, Christine A O'Mahony, Ernestina Melicoff-Portillo, William J Dreyer, Tamir A Miloh, Francisco G Cigarroa and 12 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Pediatric transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 4 pooled it
1.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 4 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.Journal of the Pediatric Infectious Diseases Society · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19 Patients Admitted for Pediatric Intensive Care.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  9. Article
  10. Impact of Respiratory Viral Infections in Transplant Recipients.Journal of the Pediatric Infectious Diseases Society · 2024
    Review
  11. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.medRxiv : the preprint server for health sciences · 2024
    Article
  12. Article
  13. SARS-CoV-2 Infection and COVID-19 in Children.Clinics in chest medicine · 2023
    Review
  14. COVID-19 in immunocompromised children and adolescents.Clinical and experimental pediatrics · 2023
    Article
  15. COVID-19 in pediatric lung transplant recipients: Clinical course and outcome.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. AMMI Canada Practice Point on the treatment of acute COVID-19 in pediatrics.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 1 country.

Matthew B GossMcGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0003-4663-0086
N Thao N GalvánDivision of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
Wenly RuanDepartment of Pediatrics, Gastroenterology, Hepatology, and Nutrition Section, Baylor College of Medicine, Houston, TX, USA.
Flor M MunozDepartment of Pediatrics, Infectious Diseases Section, Baylor College of Medicine, Houston, TX, USA.
Eileen D BrewerRenal Section, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Christine A O'MahonyDivision of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
Ernestina Melicoff-PortilloPulmonary Section, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-5696-7112
William J DreyerCardiology Section, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Tamir A MilohDivision of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL, USA.
Francisco G CigarroaDivision of Abdominal Transplantation, University Transplant Center, UT Health San Antonio, San Antonio, TX, USA.
Daniel RanchDivision of Nephrology, Department of Pediatrics, UT Health San Antonio, San Antonio, TX, USA.
Dor YoeliDivision of Transplant Surgery, Department of Surgery, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, CO, USA.ORCID 0000-0002-5041-7782
Megan A AdamsDivision of Transplant Surgery, Department of Surgery, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, CO, USA.
Sarah KoohmaraieLiver Transplantation Service, Texas Children's Hospital, Houston, TX, USA.
Diana M HarterTransplant Services, Texas Children's Hospital, Houston, TX, USA.
Abbas RanaDivision of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0003-2979-0598
Ronald T CottonDivision of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
Beth CarterDivision of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Keck School of Medicine of USC, Los Angeles, CA, USA.
Shreena PatelDivision of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Keck School of Medicine of USC, Los Angeles, CA, USA.
Nicolas F MorenoMcGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0001-8661-676X
Daniel H LeungDepartment of Pediatrics, Gastroenterology, Hepatology, and Nutrition Section, Baylor College of Medicine, Houston, TX, USA.
John A GossDivision of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
Baylor College of Medicine · USChildren's Hospital Colorado · USKeck Hospital of USC · USTexas Children's Hospital · USThe University of Texas Health Science Center at Houston · USThe University of Texas Health Science Center at San Antonio · USUniversity of Miami · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical course of COVID-19 in pediatric solid organ transplant recipients remains ambiguous. Though preliminary experiences with adult transplant recipients have been published, literature centered on the pediatric population is limited. We herein report a multi-center, multi-organ cohort analysis of COVID-19-positive transplant recipients ≤ 18 years at time of transplant. Data were collected via institutions' respective electronic medical record systems. Local review boards approved this cross-institutional study. Among 5 transplant centers, 26 patients (62% male) were reviewed with a median age of 8 years. Six were heart recipients, 8 kidney, 10 liver, and 2 lung. Presenting symptoms included cough (n = 12 (46%)), fever (n = 9 (35%)), dry/sore throat (n = 3 (12%)), rhinorrhea (n = 3 (12%)), anosmia (n = 2 (8%)), chest pain (n = 2 (8%)), diarrhea (n = 2 (8%)), dyspnea (n = 1 (4%)), and headache (n = 1 (4%)). Six patients (23%) were asymptomatic. No patient required supplemental oxygen, intubation, or ECMO. Eight patients (31%) were hospitalized at time of diagnosis, 3 of whom were already admitted for unrelated problems. Post-transplant immunosuppression was reduced for only 2 patients (8%). All symptomatic patients recovered within 7 days. Our multi-institutional experience suggests the prognoses of pediatric transplant recipients infected with COVID-19 may mirror those of immunocompetent children, with infrequent hospitalization and minimal treatment, if any, required.

Indexed as

Immunocompromised HostOrgan TransplantationAdolescentChildChild, PreschoolCOVID-19FemaleGraft RejectionHospitalizationHumansImmunosuppressive AgentsInfantInfant, NewbornMalePerioperative CareSeverity of Illness IndexImmunosuppressive Agentspediatric transplantationviral infection

Identifiers

PMID32949098
PMCPMC7537006
OpenAlexW3087253907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.